by TractManager | Feb 22, 2024 | Emerging Technology Report
Marnetegragene autotemcel (Rocket Pharmaceuticals Inc.) is an investigational gene therapy administered by intravenous infusion for the treatment of severe leukocyte adhesion deficiency-I.
by TractManager | Feb 22, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound fish skin grafts for improving healing and closure of diabetic foot ulcers (DFUs).
by TractManager | Feb 20, 2024 | Emerging Technology Report
Resamirigene bilparvovec is an investigational single-infusion gene therapy proposed for the treatment of X-linked myotubular myopathy.
by TractManager | Feb 20, 2024 | Emerging Technology Report
Human Acellular Vessel (HAV; Humacyte Inc.) is an investigational bioengineered vascular conduit proposed to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.
by TractManager | Feb 15, 2024 | Emerging Technology Report
Human Acellular Vessel (HAV; formerly Humacyl) (Humacyte Inc.) is an off-the-shelf bioengineered vascular conduit proposed for urgent arterial repair following extremity vascular trauma when a synthetic graft is not indicated, and when autologous vein use is not...
Recent Comments